MSD
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
See below for the Latest MSD News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD navigates the pandemic tapestry in COVID-19 fight
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
Join the community
Most Read
1. IHH Healthcare North Asia launches AI Lab in Hong Kong 2. India’s pharma industry to face ongoing scrutiny over quality issues 3. APAC healthcare workers voice concerns over AI, data gaps 4. NUHS app adds emergency wait times, pre-arrival health declarations 5. APAC eyes fastest growth in global body composition analysers marketResource Center
Event News
Healthcare
CooperVision unites experts to combat childhood myopia
Asia-Pacific symposium highlights urgency of pediatric myopia crisis and cross-border collaboration.
Commentary
Biomedical textiles: Novel fabrics supporting enhanced patient care in Asia-Pacific